Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
Repurposing ebselen for decolonization of vancomycin-resistant enterococci ( VRE) | PLOS ONE
Antibiotics | Free Full-Text | Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci
Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis - ScienceDirect
Epidemiological profiles and pathogenicity of Vancomycin-resistant Enterococcus faecium clinical isolates in Taiwan [PeerJ]
MIC values for linezolid among MRSA (n=50) and VRE (n=50). | Download Scientific Diagram
Risk Factors Associated with Failure of Linezolid Therapy in Vancomycin-Resistant Enterococcus faecium Bacteremia: A Retrospective Cohort Study in a Referral Center in Mexico | Microbial Drug Resistance
Linezolid: pharmacokinetic characteristics and clinical studies - Bouza - 2001 - Clinical Microbiology and Infection - Wiley Online Library
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections | Scientific Reports
PDF] Antimicrobial properties and elution kinetics of linezolid from polymethylmethacrylate. | Semantic Scholar
Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection - ScienceDirect
Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis | BMC Infectious Diseases | Full Text
MIC distributions of two antimicrobial agents against VRE strains. | Download Scientific Diagram
N21-130S009 Linezolid Clinical BPCA
Impact of a vancomycin-resistant Enterococcus (VRE) screening result on appropriateness of antibiotic therapy | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus - Khilna Patel, Rubiya Kabir, Samrah Ahmad, Steven L Allen, 2016
Resistant 'Superbugs' Create Need for Novel Antibiotics
Biomedicines | Free Full-Text | Microbial Resistance to Antibiotics and Effective Antibiotherapy
ESICM on Twitter: "❓ 1/ Answer and rationale of yesterday's #ESICMQuiz: Linezolid and quinupristin-dalfopristin are approved drugs for the treatment of VRE infections. Linezolid is not bactericidal. It is recommended for alternative
An Antibiotic Study Table Comparing VRE Drugs: Daptomycin, Linezolid, and Tigecycline
Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus - Benjamin Alan Pontefract, Suzette Amy Rovelsky, Karl Joseph Madaras-Kelly, 2020
Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis - ScienceDirect
PDF] Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE | Semantic Scholar
Daptomycin vs Linezolid for Vancomycin-Resistant Enterococcus – Dr. Germophile
Frontiers | In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
Linezolid: pharmacokinetic characteristics and clinical studies - Bouza - 2001 - Clinical Microbiology and Infection - Wiley Online Library